Hunan Fangsheng Pharmaceutical Co.Ltd(603998) ( Hunan Fangsheng Pharmaceutical Co.Ltd(603998) ) announced on March 6 that it is planned to raise no more than 270 million yuan. After deducting the issuance expenses, all the raised funds will be used to supplement working capital and repay bank loans.